Peter H. Dube
Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
Yersinia bacterium, plague, ectoparasites research, Immune Response and Inflammation, Pneumonia and Respiratory Infections, Respiratory viral infections research, Pharmacological Effects of Natural Compounds
Most-Cited Works
- → Activation of innate immune antiviral responses by Nod2(2009)716 cited
- → Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L(2020)391 cited
- → Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling(2017)148 cited
- → A MyD88-Dependent Early IL-17 Production Protects Mice against Airway Infection with the Obligate Intracellular Pathogen Chlamydia muridarum(2009)104 cited
- → Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor.(1996)98 cited
- → Delayed Inflammatory Response to Primary Pneumonic Plague Occurs in Both Outbred and Inbred Mice(2006)97 cited
- → Mycoplasma pneumoniae CARDS Toxin Induces Pulmonary Eosinophilic and Lymphocytic Inflammation(2012)97 cited
- → Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin(2009)94 cited
- → A role for IL-1α in inducing pathologic inflammation during bacterial infection(2001)70 cited
- → Infiltrated Macrophages Die of Pneumolysin-Mediated Necroptosis following Pneumococcal Myocardial Invasion(2016)70 cited